(Q42455423)

English

Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women

scientific article published on November 1, 1992

Statements

Phase I and endocrine study of exemestane (FCE 24304), a new aromatase inhibitor, in postmenopausal women (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit